Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) IPO
IPO
Priced at US$12.00 a share on Jul 18, 2024.
- Price
- US$12.00 a share
- Shares offered
- 13,920,000 shares of common stock
- Offering size
- US$167 million
- Underwriters' option
- Up to 2,088,000 more shares
- Underwriters
- Jefferies, TD Cowen, Cantor, Wedbush PacGrow, Needham & Company · In the order on the cover
- Shares delivered
- On or about Jul 22, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 3, 2024 |
| Filed publicly | Jun 28, 2024 |
| Amended once | Jul 15, 2024 |
| Shares registered with an exchange | Jul 16, 2024 |
| Declared effective by the SEC | Jul 18, 2024 |
| Final prospectus, with the price | Jul 22, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 22, 2024 |
| EFFECT · Notice that a registration is effective | Jul 18, 2024 |
| S-1MEF · Registration of more shares for the same offering | Jul 18, 2024 |
| CERT · Exchange's certificate of listing | Jul 18, 2024 |
| CORRESP · Letter to the SEC | Jul 16, 2024 |
| CORRESP · Letter to the SEC | Jul 16, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 16, 2024 |
| S-1/A · Registration statement, amended | Jul 15, 2024 |
| CORRESP · Letter to the SEC | Jul 5, 2024 |
| CORRESP · Letter to the SEC | Jun 28, 2024 |
| S-1 · Registration statement | Jun 28, 2024 |
| UPLOAD · Letter from the SEC | Jun 21, 2024 |
| DRS/A · Draft registration statement, amended | Jun 10, 2024 |
| DRSLTR · Letter to the SEC with a draft | Jun 7, 2024 |
| UPLOAD · Letter from the SEC | May 30, 2024 |
| DRS · Draft registration statement | May 3, 2024 |
From the cover of the final prospectus (424B4) filed Jul 22, 2024